2018

1. Olindo S, Jeannin S, Saint-Vil M, Signate A, Edimonana-Kaptue M, Joux J, Merle H, Richard P, Granjeaud S, Cabre P, Smadja D, Cesaire R, Lezin A. Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010). PLoS Negl Trop Dis. 2018 Mar 19;12(3):e0006304.
2. Tang Y, George AM, Petrechko O, Nouvet FJ, Sweet SD, Tanaka Y, Imbiakha BS, Jiang G, Gao W, Anastos K, Hildreth JEK. Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1. mSphere. 2018 Apr 4;3(2). pii: e00038-18.
3. Nakaya Y, Tsutsumi M, Fuseya H, Horiuchi M, Yoshimura T, Hayashi Y, Kanashima H, Nakao T, Yamane T. [Long-term remission with mogamulizumab monotherapy in a patient with refractory adult T-cell leukemia-lymphoma]. Rinsho Ketsueki. 2018;59(3):326-328.
4. Refaat A, Owis M, Abdelhamed S, Saiki I, Sakurai H. Retrospective screening of microarray data to identify candidate IFN-inducible genes in a HTLV-1 transformed model. Oncol Lett. 2018 Apr;15(4):4753-4758.
5. Tanaka A, Matsuoka M. HTLV-1 Alters T Cells for Viral Persistence and Transmission. Front Microbiol. 2018 Mar 20;9:461.
6. Kulkarni A, Bangham CRM. HTLV-1: Regulating the Balance Between Proviral Latency and Reactivation. Front Microbiol. 2018 Mar 19;9:449.
7. Nakamura H, Hasegawa H, Sasaki D, Takatani A, Shimizu T, Kurushima S, Horai Y, Nakashima Y, Nakamura T, Fukuoka J, Kawakami A. Detection of human T lymphotropic virus type-I bZIP factor and tax in the salivary glands of Sjögren's syndrome patients. Clin Exp Rheumatol. 2018 Mar 20.
8. Levi JE. Emerging Infectious Agents and Blood Safety in Latin America. Front Med (Lausanne). 2018 Mar 14;5:71.
9. Pasquier A, Alais S, Roux L, Thoulouze MI, Alvarez K, Journo C, Dutartre H, Mahieux R. How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy. Front Microbiol. 2018 Mar 13;9:278.
10. Martins ML, de Freitas Carneiro-Proietti AB, Nicolato R, de Miranda DM, Romanelli LCF. HTLV-1 proviral load in cerebrospinal fluid may not be a good marker to differentiate asymptomatic carriers with high proviral load in blood from HAM/TSP patients. J Neurovirol. 2018 Mar 27.
11. Hasegawa H, Sano K, Ainai A, Suzuki T. Application of HTLV-1 tax transgenic mice for therapeutic intervention. Adv Biol Regul. 2018 Feb 13. pii:S2212-4926(18)30075-7.
12. Jeannin P, Chaze T, Giai Gianetto Q, Matondo M, Gout O, Gessain A, Afonso PV. Proteomic analysis of plasma extracellular vesicles reveals mitochondrial stress upon HTLV-1 infection. Sci Rep. 2018 Mar 26;8(1):5170.
13. Schatz M, Tong PBV, Beaumelle B. Unconventional secretion of viral proteins. Semin Cell Dev Biol. 2018 Mar 24. pii: S1084-9521(17)30113-1.
14. Bureta CA, Abematsu M, Tominaga H, Saitoh Y, Kawamura I, Nagano S, Setoguchi T, Ishidou Y, Yamamoto T, Komiya S. Hypertrophic spinal pachymeningitis associated with human T-cell lymphotrophic virus-1 infection and Sjogren's syndrome: A case report and brief literature review. Int J Surg Case Rep. 2018 Mar 15;45:22-28.
15. Einsiedel L, Purcell D, Schinke S, Haynes K, Taylor GP, Martin F. Highlights from the HTLV-1 symposium at the 2017 Australasian HIV and AIDS Conference held jointly with the 2017 Australasian Sexual Health Conference, November 2017, Canberra, Australia. J Virus Erad. 2018 Jan 1;4(1):48-50.
16. Pérès E, Blin J, Ricci EP, Artesi M, Hahaut V, Van den Broeke A, Corbin A, Gazzolo L, Ratner L, Jalinot P, Duc Dodon M. PDZ domain-binding motif of Tax sustains T-cell proliferation in HTLV-1-infected humanized mice. PLoS Pathog. 2018 Mar 22;14(3):e1006933.
17. Donhauser N, Heym S, Thoma-Kress AK. Quantitating the Transfer of the HTLV-1 p8 Protein Between T-Cells by Flow Cytometry. Front Microbiol. 2018 Mar 7;9:400.
18. Shi XM, Fan GC, Tang X, Shen Q, Zhu JJ. Ultrasensitive photoelectrochemical biosensor for the detection of HTLV-I DNA: A cascade signal amplification strategy integrating λ-exonuclease aided target recycling with hybridization chain reaction and enzyme catalysis. Biosens Bioelectron. 2018 Jun 30;109:190-196.
19. Nobre AFS, Almeida DS, Ferreira LC, Ferreira DL, Júnior ECS, Viana MNDSA, Silva IC, Pinheiro BT, Ferrari SF, Linhares ADC, Ishikawa EA, Sousa RCM, de Sousa MS. Low genetic diversity of the Human T-cell Lymphotropic Virus (HTLV-1) in an endemic area of the Brazilian Amazon basin. PLoS One. 2018 Mar 20;13(3):e0194184.
20. Carvalho NB, de Lourdes Bastos M, Souza AS, Netto EM, Arruda S, Santos SB, Carvalho EM. Impaired TNF, IL-1β, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals. Tuberculosis (Edinb). 2018 Jan;108:35-40.
21. van Tienen C, Visser O, Lugtenburg P, Taylor G, Cook L. Overrepresentation of patients from HTLV-1 endemic countries among T cell Non-Hodgkin lymphomas in the Netherlands: an indication of under-diagnosis of Adult T cell leukaemia/lymphoma. Br J Haematol. 2018 Mar 12.
22. Salehi M, Ghasemian A, Shokouhi Mostafavi SK, Najafi S, Rajabi Vardanjani H. Sero-prevalence of Helicobacter pylori Infection in Neyshabur, Iran, During 2010-2015. Iran J Pathol. 2017 Spring;12(2):183-188.
23. Fochi S, Mutascio S, Bertazzoni U, Zipeto D, Romanelli MG. HTLV Deregulation of the NF-κB Pathway: An Update on Tax and Antisense Proteins Role. Front Microbiol. 2018 Feb 21;9:285.
24. Einsiedel L, Pham H, Wilson K, Walley R, Turpin J, Bangham C, Gessain A, Woodman RJ. Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians. PLoS Negl Trop Dis. 2018 Mar 12;12(3):e0006281.
25. Yamanashi H, Koyamatsu J, Nagayoshi M, Shimizu Y, Kawashiri SY, Kondo H, Fukui S, Tamai M, Sato S, Yanagihara K, Kawakami A, Maeda T. Human T-cell Leukemia Virus-1 Infection is Associated with Atherosclerosis as Measured by Carotid Intima-Media Thickness in Japanese Community-Dwelling Older People. Clin Infect Dis. 2018 Feb 26.
26. Moreno-Ajona D, Yuste JR, Martín P, Gállego Pérez-Larraya J. HTLV-1 myelopathy after renal transplant and antiviral prophylaxis: the need for screening. J Neurovirol. 2018 Mar 12.
27. Cherian MA, Olson S, Sundaramoorthi H, Cates K, Cheng X, Harding J, Martens A, Challen GA, Tyagi M, Ratner L, Rauch D. An activating mutation of interferon regulatory factor 4 (IRF4) in adult T cell leukemia. J Biol Chem. 2018 Mar 14. pii: jbc.RA117.000164.
28. Malpica L, Pimentel A, Reis IM, Gotuzzo E, Lekakis L, Komanduri K, Harrington T, Barber GN, Ramos JC. Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States. Blood Adv. 2018 Mar 27;2(6):607-620.
29. Ishikawa C, Senba M, Mori N. Effects of NVP-BEZ235, a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, on HTLV-1-infected T-cell lines. Oncol Lett. 2018 Apr;15(4):5311-5317.
30. Sharma PV, Witteman M, Sundaravel S, Larocca T, Zhang Y, Goldsztajn H. A case of HTLV-1 associated adult T-cell lymphoma presenting with cutaneous lesions and tropical spastic paresis. Intractable Rare Dis Res. 2018 Feb;7(1):61-64.
31. Alves FA, Campos KR, Lemos MF, Moreira RC, Caterino-de-Araujo A. Hepatitis C viral load in HCV-monoinfected and HCV/HIV-1-, HCV/HTLV-1/-2-, and HCV/HIV/HTLV-1/-2-co-infected patients from São Paulo, Brazil. Braz J Infect Dis. 2018 Apr 3. pii: S1413-8670(17)31046-2.